Tag:
Dusa Pharmaceuticals
Latest Headlines
Latest Headlines
Dusa shares crater on trial failure
Shares of Dusa Pharmaceuticals were hammered by the news that the developer is dropping development of its Levulan Photodynamic Therapy for moderate to severe acne it flunked a mid-stage trial. Its
